Molina Healthcare, Inc
MOH Healthcare Healthcare Plans
Molina Healthcare, Inc’s revenue for fiscal 2025 (year ended December 2025) was $45.4 billion, up 11.7% from fiscal 2024. In the quarter to June 2026, revenue fell 4.84%, EPS fell 75.0%, free cash flow grew 5.81% and total debt rose 10.9%, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.
Follow MOH
Molina Healthcare, Inc (MOH) EV/Sales
As of 13 October 2026, Molina Healthcare, Inc (MOH) trades at a EV/Sales of 0.1×. Over the past ten years it has ranged from −0.1× (March 2017) to 0.6× (January 2021); the current reading is higher than 39% of that period. That is below the Healthcare Plans industry median of 0.4× and below the Healthcare sector median of 3.5×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 0.1× | (59.77%) |
| FY2024 | 0.3× | (38.25%) |
| FY2023 | 0.4× | 3.67% |
| FY2022 | 0.4× | (11.94%) |
| FY2021 | 0.5× | 3.47% |
| FY2020 | 0.5× | 39.45% |
| FY2019 | 0.3× | 53.58% |
| FY2018 | 0.2× | 546.22% |
| FY2017 | 0.0× | 1,476.19% |
| FY2016 | 0.0× | (95.08%) |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 0.2× | 353.89% |
| Mar 2026 | 0.0× | (68.93%) |
| Dec 2025 | 0.1× | (12.53%) |
| Sep 2025 | 0.1× | (50.36%) |
| 42 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| CNC Centene Corporation compare | 0.1× |
| MOH Molina Healthcare, Inc | 0.1× |
| HUM Humana Inc. compare | 0.3× |
| ALHC Alignment Healthcare, Inc. compare | 0.3× |
| CI Cigna Group compare | 0.4× |
| ELV Elevance Health, Inc. compare | 0.4× |
| OSCR Oscar Health, Inc. compare | 0.4× |
| CLOV Clover Health Investments, Corp. compare | 0.9× |
| PGNY Progyny, Inc. compare | 1.5× |
| Healthcare Plans industry median | 0.4× |
| Healthcare sector median | 3.5× |
| Market median | 2.2× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)